Preliminary Study Suggests Johnson & Johnson COVID Vaccine May Not Be As Effective Against Delta Variant
Preliminary Study Suggests Johnson & Johnson COVID Vaccine May Not Be As Effective Against Delta Variant

The Delta variant of the coronavirus is spreading and is now responsible for 83% of new COVID cases in the United States.

A new study suggests the Johnson & Johnson vaccine may not be as effective fighting that variant; CBS2's Dr. Max Gomez reports.